1. Home
  2. Health
  3. Bipolar Disorder
Klonopin / Rivotril (generic name clonazepam) is a benzodiazepine sometimes prescribed to alleviate anxiety and difficulty sleeping for those with bipolar disorder (manic depression). Found here are resources and information relating to this medication.
Klonopin Medication Profile
Klonopin - generic clonazepam, sold outside the United States as Rivotril - is a medication used to treat anxiety and panic disorder as well as certain seizure disorders. It is a benzodiazepine medication. This article covers precautions and warnings, recommended dosage, and common side effects.
Klonopin Side Effects
Catalogue of side effects for the medication Klonopin or Rivotril - generic clonazepam - an anticonvulsant which may be prescribed as a mood stabilizer in the treatment of bipolar disorder. Klonopin is a benzodiazepine.
Klonopin / Rivotril / Clonazepam Drug Info & Pictures
Detailed information on Klonopin / Rivotril (clonazepam) from Drugs A-Z. Click on "More Images" for pictures of brand and generic tablets.
Clonazepam Monograph
This is a comprehensive Canadian monograph from Internet Mental Health. Contents include pharmacology, indications, contraindications, warnings, precautions, overdose information and dosage.
Roche U.S. Pharmaceuticals
This is the offical home page published by Roche U.S. Pharmaceuticals for the drug Klonopin. This site offers complete product information in pdf format.
RxList Monograph
A comprehensive monograph from RxList, including pharmacology, indications and dosage, precautions, warnings, side effects, patient information and more.
Explore Bipolar Disorder
About.com Special Features

8 Ways to Cut Drug Costs

Learn how to save money on medications with these recommendations. More >

Healthy Bodies, Healthy Minds

Keep yourself, and your family, happy and healthy this fall with these tips. More >

  1. Home
  2. Health
  3. Bipolar Disorder
  4. Medications
  5. Anti-Anxiety and Sedatives
  6. Benzodiazepines
  7. Klonopin / Rivotril

©2009 About.com, a part of The New York Times Company.

All rights reserved.